TARS Competitors & Alternatives
Compare Tarsus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
TARS
Main Stock$65.44
Tradestie Score
63
Market Cap
$2.42B
Revenue Growth
1.1%
Analyst Upside
+43.8%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$33.47
|
$2.89B | - | 56 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$38.79
|
$2.85B | - | 61 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.45
|
$2.56B | 18.2 | 57 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$34.79
|
$2.44B | - | 62 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$146.63
|
$2.41B | - | 58 | Compare |
|
IDYA
IDEAYA Biosciences, Inc. Common Stock
|
$37.65
|
$2.40B | - | 60 | Compare |
|
FOLD
Amicus Therapeutics, Inc
|
$14.49
|
$2.38B | - | 60 | Compare |
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.81
|
$2.37B | - | 59 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.91
|
$2.35B | - | 59 | Compare |
More TARS Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry